Cellectar Biosciences is back in focus after its fair value estimate was reset from US$76.00 to about US$10.33, a sharp shift ...

T (ACNA) has moved up the trial of Archbishop Stephen Wood by over a month.   Wood, the head of the theologically ...

Learning Resources® Family of Brands, pioneers in educational toys and hands-on learning tools for over 60 years, is expanding its availability at Target ahead of the back-to-school season. The ...

Recent interest in Pfizer (PFE) has been driven by U.S. regulators approving IBRANCE as the first CDK4/6 inhibitor ...

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer ...

Summary: Investigators demonstrated that an experimental compound called BA-101 can successfully strip away glioblastoma’s defensive armor. By selectively blocking an enzyme that fuels the tumor’s ...

As Bristol Myers Squibb attempts to convert two accelerated oncology nods for Krazati into traditional FDA approvals, the ...

A new study reveals that axon formation is driven by an internal molecular zipper protein complex called Arp2/3.

A SHAMED Olympic star who gang raped a tourist with three other men is jailed after he won a medal while on trial. Antonino ...

Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...

Biogen Inc. (NASDAQ:BIIB) is one of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now. On June 29, it was reported that ...